Furthermore, other than cancer, Gal-3 shows promise as a biomarker for many other diseases including hepatitis [21], cardiovascular diseases [22], chronic kidney disease and Alzheimer’s disease [23]. The gene discussed is LGALS3; the disease is early-onset autosomal dominant Alzheimer disease.